Hortapharm B.V.
HortaPharm B.V. is a cannabis research and development business in the Netherlands.[2]
| Industry | Horticulture |
|---|---|
| Founded | 1990 |
| Founder | David Paul Watson |
| Headquarters | , |
| Products | Cannabis based medicine extracts |
History
The business was founded by David Paul Watson in 1990. He was soon joined by David W. Pate and eventually Robert C. Clarke. They obtained the first license issued by the Dutch government to permit a Cannabis research facility in the Netherlands. In 1998, HortaPharm B.V. began partnering with GW Pharmaceuticals to develop Cannabis varieties for the manufacture of pharmaceuticals.[3][4]
Breeding
Using selective breeding and production control, HortaPharm created Cannabis strains that produce virtually single cannabinoids, approximately 98% tetrahydrocannabinol or cannabidiol, relative to the total of other cannabinoids present.[5]
gollark: Bitcoin ASICs just have all the logic for SHA256, directly burned (well, magically siliconed) into hardware.
gollark: CPUs do tons of difficult complex stuff to run general purpose code very fast.
gollark: Not in general. They can only do one thing.
gollark: At bitcoin mining, yes.
gollark: Well, double SHA256 but whatever.
References
- "Archived copy". Archived from the original on 2013-10-05. Retrieved 2012-07-19.CS1 maint: archived copy as title (link)
- The Inheritance of Chemical Phenotype in Cannabis sativa L.(HortaPharm B.V., 1075 VS, Amsterdam, The Netherlands)
- Breen, Bill (2004-02-01). "Dr. Dope's Connection". Fast Company. Retrieved 2019-08-07.
- "Details released of collaboration between GW Pharmaceuticals and Hortapharm medicinal cannabis,". Archived from the original on 2012-07-30. Retrieved 2012-07-19.
- Janet E. Joy; Stanley J. Watson Jr.; John A. Benson Jr. (1999), Marijuana and Medicine, National Academies Press, ISBN 9780309071550
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.